APOE and atherosclerosis: To investigate the role of miR-19b-containing EMPs in the development of atherosclerosis, 6-week-old ApoE-/- mice fed a high-fat diet were treated with PBS, EMPcontrol, or EMPmiR-19b three times per week by tail vein injection (Figure 2A).